Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy Journal Article


Author: Moskowitz, C.
Article Title: Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
Abstract: At Memorial Sloan Kettering Cancer Center, New York, we have treated over 400 patients with ICE chemotherapy after failure of upfront anthracycline-based therapy with a response rate of 72% in aggressive non-Hodgkin's lymphoma (NHL) and 84% in Hodgkin's disease. Utilizing this database, we have identified pretreatment prognostic markers capable of predicting the quality of response (complete response vs partial response vs failure) to second-line cytoreductive ICE chemotherapy and consequently autologous stem cell transplantation. We have shown that in aggressive NHL, patients achieving a complete response have superior survival when compared to those achieving only a partial response. By identifying a priori those patients destined to have only a partial response to ICE, we will be able to target a group of chemosensitive patients who are most likely to benefit from improved treatment. Novel treatment strategies designed to increase their complete response rate would be anticipated to improve their long-term survival.
Keywords: cancer chemotherapy; cancer survival; treatment outcome; disease-free survival; treatment failure; clinical trial; cancer recurrence; dose response; drug safety; nonhuman; conference paper; cancer radiotherapy; carboplatin; etoposide; antineoplastic combined chemotherapy protocols; drug administration schedule; stem cell transplantation; chemosensitivity; data base; prediction; ifosfamide; hodgkin disease; radiation response; risk; survival time; lymphoma, b-cell; nonhodgkin lymphoma; randomized controlled trials; lymphoma, non-hodgkin; anthracycline; ice chemotherapy; humans; prognosis; human; priority journal; risk-adapted therapy; refractory lymphoma
Journal Title: Cancer Chemotherapy and Pharmacology
Volume: 49
Issue: 1 Suppl.
ISSN: 0344-5704
Publisher: Springer  
Date Published: 2002-04-01
Start Page: S9
End Page: S12
Language: English
PUBMED: 12042983
PROVIDER: scopus
DOI: 10.1007/s00280-002-0446-2
DOI/URL:
Notes: Presented at ECCO's 11th Meeting; 2001 Oct 21; Lisbon, Portugal -- Export Date: 14 November 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz